Navigation Links
Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
Date:6/10/2008

tter positioned than Mylan to help us unlock the extraordinary value of this product in the United States and around the world. We are truly excited about our collaboration."

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies

NATCO Pharma Limited, based in Hyderabad, India, is ranked among the fastest growing pharmaceutical companies in the country. It manufactures branded and generic dosage forms, bulk actives and intermediates for Indian and international markets. During its 24-year history, NATCO has gained a reputation for innovative product development, high-quality manufacturing capabilities and strong financial growth.

Copaxone(R) is a registered trademark of Teva Pharmaceutical Industries Ltd.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Mylan Announces Final FDA Approval for Zaleplon Capsules
2. Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
3. Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
4. Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
5. Mylan Declares Quarterly Preferred Stock Dividend
6. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
7. Mylan Announces Final FDA Approval for Trandolapril Tablets
8. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
9. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
10. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
11. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...as too short to draw definite conclusions, experts... News) -- In diabetic patients with blocked corona...outcomes at one year whether patients undergo bypa...esearchers report. , Bypass surgery has been th...ronary artery disease. However, less invasive appr...
(Date:11/25/2009)... lead mothers to overlook needed care, study finds... -- A mother,s depression can worsen her child,s a...-month study of 262 black mothers and their childr...essive symptoms had more frequent asthma symptoms,...ymptoms had less frequent asthma symptoms. , Th...
(Date:11/25/2009)...swire/-- MISSIONSkincare ®isproudtosupportGNC...ofGNC,sannualSt.Jude ThanksandGiving campaign,$1fr...SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Addition...10donationatcheckoutatoneoftheir5,000+retaillocati...St.Judeduringtheir2009 ThanksandGiving campaign. ,...
(Date:11/25/2009)...er vaccine carried into the body on a carefully en... successfully eliminate tumors in mammals, scienti...lational Medicine . , The new approach, pioneere...versity, uses plastic disks impregnated with tumor... reprogram the mammalian immune system to attack t...
(Date:11/25/2009)...the skin kill tumor cells, study finds , ... vaccine delivered in a fingernail-size implant el...rts. , The method uses polymer disks, 8.5 milli...cific antigens and implanted under the skin to rep...vard University scientists who developed the impla...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...0th as the 33rd Great American Smokeout sponsored ...nity Pharmacists Association House of Delegates ha...ers to consider refraining from selling tobacco pr...ucts is an unhealthy and potentially deadly habit,...
...people who,suffer from a stroke, the underlying ca...s. Atrial fibrillation (AF), or an irregular hear...any of these cases. , Stroke researchers at ... ) that a new,diagnostic approach that extends the...
...s report , , WEDNESDAY, Nov. 19 (HealthDay...reviously unnoticed bone abnormalities in adolesce...ia. , "What we have found in this study is an exci...one density. We show abnormalities of bone structu...
...pheric Research (UCAR), working with an internatio...aunching a project this month to provide long-term...to help reduce outbreaks of meningitis. The foreca... conditions. , "We,re applying our expertise in w...
...h information. And more is coming. At The Universi...at Houston (SHIS), research trainees are learning ...sion in e-information. , SHIS recently received a...lth information technology (Health IT). Four of th...
...nation,s,largest provider of home care and health ...f the "National Quality Awards" for 2008 at their ...nnah, Georgia. The awards recognize Interim,home ...er,the introduction of the CMS (Centers for Medica...
Other Medicine News:Health News:NCPA Encourages Member Pharmacists to Consider Refraining From Selling Tobacco Products 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 2Health News:Study Suggests Need for More Aggressive Outpatient Monitoring of Patients' Hearts When Cause of Stroke is Unclear 3Health News:New Scan Spots Beginning of Bone Problems in Anorexics 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 3Health News:UT trainees tackle health information technology issues 2Health News:UT trainees tackle health information technology issues 3Health News:Interim HealthCare Recognizes Outstanding Franchisees at National Clinical Symposium 2Health News:Interim HealthCare Recognizes Outstanding Franchisees at National Clinical Symposium 3
(Date:11/25/2009)...stCall/--ChinaSkyOne,Medical,Inc.("ChinaSkyOneMedi...ntegratedpharmaceuticalcompanydevelopingandproduci...na("PRC"),today,announcedthattheCompanyrecentlypas...maceuticalandBiologicalProducts("ICPBP")examinatio...rostateSpecific,Antigen(ColloidalGold)anditsDeterm...
(Date:11/25/2009)...r.comannouncesthatanewmarketresearchreportisavaila...lobalMarketPerspective ,, http://www.reportl...l-Market-Perspective.html ,, Risingincidenceof...onsisaprincipalfactorinfluencinggrowthinthemammogr...cancerhasallowedwomentocomeforwardfortheiryearlyma...
(Date:11/25/2009)...SwissrayInternational,Inc.aleadingmanufacturerofdi...ythatitsoperationshavebeenacquiredbyaprivateSwissI...dicalimagingbrand.Theacquisitionincludedallassetsa...ry.After25yearsofsuccessandgrowthSwissrayisnowpois...ithstableandsteadygrowth. ,, "Swissrayhaslongbe...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Swissray International Announces New Ownership 2Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 1Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 2Dr Benjamin Raab of Naperville IL Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51349 3CBCA Administrators Inc Announces Partnership with Bravo Wellness 51346 1CBCA Administrators Inc Announces Partnership with Bravo Wellness 51346 2RF Walsh Collaborative Partners Celebrates New Name 26 Expansion 51343 1RF Walsh Collaborative Partners Celebrates New Name 26 Expansion 51343 2RF Walsh Collaborative Partners Celebrates New Name 26 Expansion 51343 3
Shandon Microscope Slide Trays
... PSL utilizes a high luminance white LED (Light Em...ight, compact design, to give you the freedom of u...amp weighs only about 1.5 lbs. (0.68 kg) with its ...nd. Its ergonomic, portable design and convenient...
3S LED HeadLight
...a Trol™ Abnormal Control Serum is intended f...ly used clinical chemistry assays. It is for in vi...ophilized format, the control offers up to ten day...control is to be used in accordance with the direc...
Medicine Products: